CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules…

Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP

Read the official FDA notice

Published
30 Apr 2025
Units affected
2724 bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01

Brand / company
Lupin Pharmaceuticals Inc.
Codes / lots
Lot #: M300442, Exp Date: 6/30/2025
Distribution
USA nationwide
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 30 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.